Home
Sanofi

Sanofi Market Share Analysis for June 2026

Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. The corporation was established in 1973 and merged with Synthélabo in 1999 to form Sanofi-Synthélabo.

Health > Pharmacy

Domainsanofi.ca

Year Founded1973

Employees> 10001

Annual Revenue> $1B

Sanofi

Sanofi (including company regionals)

sanofi.ca

See more website traffic and engagement information

Sanofi Revenue up to June 2026 is > 1B

revenue generated by Sanofi top domains

Sanofi top domains revenue over 3 years

Revenue for Sanofi top domains

sanofi.ca> 1B

See more with Sales Intelligence

Sanofi Stock price in June 2026

Sanofi stock is traded under the ticker #SNY. Below you can review Sanofi stock performance in the past 12 months up to June 2026

Total visits to Sanofi's top domains

Understand Sanofi market share and potential market reach.

Total visits last 3 months

No Data to Display

Avg. visit duration in Sanofi's top domains

Analyze Sanofi engagement metrics.

Average visit duration last 3 months

No Data to Display

Avg. pageviews on Sanofi's top domains

See how Sanofi keep users engaged, nurture their interest, and encourage them to take the next step.

Average page views last 3 months

No Data to Display

Sanofi top competitors by domain

Top similar sites in June 2026, ranked by their affinity

pfizer.caCompany NamePfizerEmployees> 10001HQUnited States, New York, New York CityAnnual revenue> $1BTotal visits20KHealth > Pharmacy

Top technologies used by Sanofi

These are the website technologies, by industry, used by Sanofi top domains

Audio Video Media (4)

YouTube

Social (4)

Instagram

Content Management System (3)

Launch Darkly

Conversion & Analytics (3)

Google Analytics

More Technologies

11

See all

News & Signals from Sanofi

With Similarweb Sales signals alerts, you’ll receive daily updates of recognized buying signals whenever new opportunities or threats arise in your target audience.

Newssanofi aventis Canada inc. sold assets to Lupin Pharmaceuticals, Inc. on Dec 22nd '23.Home-grown pharma major Lupin Ltd on Friday said it acquired a portfolio of established products in Europe and Canada from Sanofi for a purchase consideration of EUR 10 million (Rs 91 crore).

NewsLupin Ltd. partnered with sanofi aventis Canada inc. on Mar 31st '23.Lupin Ltd has informed the stock exchanges that its wholly-owned subsidiary, Lupin Atlantis Holdings SA, Switzerland, has entered into an asset purchase agreement with Sanofi, a French multinational pharmaceutical and healthcare company, to acquire a portfolio of products in Europe and Canada for a purchase consideration of ₹91 crore and sales up to ₹72.8 crore.

Newssanofi aventis Canada inc. received financing of $415M in federal funds on Jan 1st '21.Canada's federal government could have taken advantage of a strategic opportunity to ensure access to rifapentine when, in 2021, Sanofi received $415 million in federal funds to build a flu vaccine-manufacturing plant in Canada.